Beshai Rafail, Lee Jeffrey J
Internal Medicine, Jefferson Health New Jersey, Stratford, USA.
Cardiology, Cooper University Hospital, Camden, USA.
Cureus. 2022 May 27;14(5):e25398. doi: 10.7759/cureus.25398. eCollection 2022 May.
COVID-19 is a serious disease with high morbidity and mortality around the globe. We present a case of a 45-year-old male who presents with substernal chest pain three days after receiving the second dose of his COVID-19 mRNA (Moderna) vaccine. A transthoracic echo showed reduced left ventricular ejection fraction of 25-30% with akinesis of the mid to distal anterior, anteroseptal, anterolateral, inferolateral, inferoseptal, and inferior walls. Patient symptoms improved significantly during his hospitalization. Repeat trans-thoracic echo four days after his hospitalization showed ejection fraction recovery without segmental wall motion abnormalities. This case demonstrates the importance of recognizing Takotsubo cardiomyopathy as a complication of COVID-19 vaccine.
新冠病毒病（COVID-19）是一种在全球范围内发病率和死亡率都很高的严重疾病。我们报告一例45岁男性病例，该患者在接种第二剂新冠病毒mRNA（Moderna）疫苗三天后出现胸骨后胸痛。经胸超声心动图显示左心室射血分数降低至25%-30%，前壁、前间隔、前侧壁、下侧壁、下间隔和下壁中至远端运动减弱。患者住院期间症状显著改善。住院四天后复查经胸超声心动图显示射血分数恢复，且无节段性室壁运动异常。该病例证明了认识到应激性心肌病是新冠病毒疫苗并发症的重要性。
